Provided by Tiger Fintech (Singapore) Pte. Ltd.

Assembly Biosciences

12.11
-0.2300-1.86%
Post-market: 12.110.00000.00%16:18 EDT
Volume:7.11K
Turnover:88.77K
Market Cap:90.87M
PE:-1.81
High:12.71
Open:12.41
Low:12.11
Close:12.34
Loading ...

Assembly Biosciences Doses First Participant in Phase 1a Clinical Study of Oral Entry Inhibitor Candidate ABI-6250 for Hepatitis Delta Virus

GlobeNewswire
·
26 Feb

ADVISORY-Alert on executive appointment wrongly tagged to Assembly Biosciences withdrawn

Reuters
·
08 Jan

Kacper KŁOs Named CEO of Assembly Digital Commerce

THOMSON REUTERS
·
08 Jan

Gilead Buys $20.1 Million of Assembly Biosciences Stock -- Barron's

Dow Jones
·
04 Jan

Gilead Buys $20.1 Million of Assembly Biosciences Stock

Dow Jones
·
30 Dec 2024

H.C. Wainwright Sticks to Its Hold Rating for Assembly Biosciences (ASMB)

TIPRANKS
·
27 Dec 2024

H.C. Wainwright stays Neutral on Assembly Biosciences after ABI-4334 data

TIPRANKS
·
27 Dec 2024

Assembly Biosciences Shares Rise on Results from Hepatitis B Drug Trial

Dow Jones
·
26 Dec 2024

Assembly Biosciences Says Antiviral Drug Shows 'Encouraging' Phase 1 Results

MT Newswires Live
·
26 Dec 2024

Assembly Biosciences announces interim PK, efficacy from Phase 1b study

TIPRANKS
·
26 Dec 2024

Assembly Biosciences Inc - Abi-4334 Well-Tolerated With Favorable Safety Profile

THOMSON REUTERS
·
26 Dec 2024

Assembly Biosciences Reports Interim Phase 1B Results From Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate Abi-4334 in Chronic Hepatitis B

THOMSON REUTERS
·
26 Dec 2024

Assembly Biosciences Reports Interim Phase 1b Results from Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 in Chronic Hepatitis B

GlobeNewswire
·
26 Dec 2024

Josh Berman Joins Assembly as Evp, Assembly Lead in North America

THOMSON REUTERS
·
21 Dec 2024

Assembly Biosciences Says It Will Receive $30.1 Million Funding From Gilead Sciences

MT Newswires Live
·
19 Dec 2024

Assembly Biosciences announces $30.1M investment, funding from Gilead

TIPRANKS
·
19 Dec 2024

Assembly Biosciences Gets $30.1M Equity Investment, Funding From Gilead

Dow Jones
·
19 Dec 2024

Assembly Biosciences Inc - Co Expects Cash Runway to Extend to Mid-2026

THOMSON REUTERS
·
19 Dec 2024

Assembly Biosciences Announces $30.1 Million Equity Investment and Accelerated Funding From Gilead to Advance Clinical Development Programs

THOMSON REUTERS
·
19 Dec 2024

Press Release: Assembly Biosciences Announces $30.1 Million Equity Investment and Accelerated Funding from Gilead to Advance Clinical Development Programs

Dow Jones
·
19 Dec 2024